The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Estimated Net Asset Value at 31 December 2016

16 Jan 2017 07:00

RNS Number : 1447U
Standard Life Euro Pri Eqty Tst PLC
16 January 2017
 

16 January 2017

STANDARD LIFE EUROPEAN PRIVATE EQUITY TRUST PLC ("SLEPET" OR "THE COMPANY") ANNOUNCES ITS ESTIMATED NET ASSET VALUE ("NAV") AT 31 DECEMBER 2016

· ESTIMATED NAV AT 31 DECEMBER 2016 WAS 343.8 PENCE PER SHARE (ESTIMATED NAV AT 30 NOVEMBER 2016 WAS 342.3 PENCE PER SHARE)

· SLEPET PAID £13.0 MILLION OF DRAW DOWNS AND RECEIVED £16.9 MILLION OF DISTRIBUTIONS DURING THE MONTH OF DECEMBER

· OUTSTANDING COMMITMENTS OF £313.9 MILLION AT 31 DECEMBER 2016

SLEPET's valuation policy for private equity funds is based on the latest valuations reported by the managers of the funds in which the Company has interests. In the case of SLEPET's valuation at 31 December 2016, 98.7% by value of the portfolio valuations were dated 30 September 2016.

 

Estimated NAV

At 31 December 2016, SLEPET's estimated NAV was 343.8 pence per share (estimated net assets £528.5 million), representing a 0.4% per share increase from the estimated NAV at 30 November 2016 of 342.3 pence per share (estimated net assets £526.3 million). The 1.5 pence increase in NAV primarily reflected realised gains and income from the underlying investments, offset by unrealised foreign exchange losses arising from a 0.5% depreciation in the euro versus sterling during December.

 

Draw downs and distributions

SLEPET paid £13.0 million of draw downs and received £16.9 million of distributions during the month. The distributions received generated net realised gains and income of £10.2 million.

 

Secondary activity

The Company acquired through a secondary purchase an original commitment of €20.0 million to Nordic Capital VII. The purchase price for the fund interest was €22.1 million, equivalent to a small premium of 2.0% to the most recent valuation date of 30 September 2016, adjusted for subsequent cashflows. The Company assumed outstanding commitments of £0.9 million on acquisition. The Company has existing commitments of €15.0 million and €30.0 million to Nordic Capital Fund VII and VIII respectively.

 

Commitments

The Company had £313.9 million of outstanding commitments at 31 December 2016. After undertaking a detailed review, the Manager continues to believe that around £55 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

Balance sheet and credit facility

The Company had liquid resources of £107.4 million at 31 December 2016. In addition, the Company has an undrawn £80 million syndicated revolving credit facility, provided by Citibank and Societe Generale that expires in December 2020.

 

Future announcements

The Company is expecting to announce its estimated NAV at 31 January 2017 on 14 February 2017.

 

Additional detail about SLEPET's NAV and investment diversification can be found on SLEPET's website. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website is incorporated into, or forms part of, this announcement.

For further information please contact Roger Pim or Peter McKellar at SL Capital Partners LLP (0131 245 0055)

Note:-

Standard Life European Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life European Private Equity Trust PLC is independent of Standard Life plc.

Valuation Methodology

Unquoted investments are stated at the directors' estimate of fair value and follow the recommendations of EVCA and BVCA. The estimate of fair value is normally the latest valuation placed on a fund by its manager at the balance sheet date. The valuation policies used by the manager in undertaking that valuation will generally be in line with the joint publication from EVCA and BVCA, 'International Private Equity and Venture Capital Valuation guidelines'. Where formal valuations are not completed at the balance sheet date the last available valuation from the fund manager is adjusted for any subsequent cashflows occurring between the valuation date and the balance sheet date. The Company's Manager may further adjust such valuations to reflect any changes in circumstances from the last manager's formal valuation date to arrive at the estimate of fair value. Quoted investments are valued based on quoted prices as of the last day of the relevant period.

The Company intends to release regular estimated NAV updates around ten business days after each month end, while continuing to issue quarterly trading statements. A breakdown of SLEPET's portfolio can be obtained in the latest monthly factsheet, which is published on the Manager's website at www.slcapital.com/IT_European_Private_Equity/getLatest.pdf

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVSFWFFDFWSESF
Date   Source Headline
4th Oct 20161:15 pmRNSQuarterly Disclosure
29th Sep 20167:00 amRNSEstimated Net Asset Value as at 31 August 2016
29th Sep 20167:00 amRNSQuarterly Trading Statement
26th Sep 201611:32 amRNSDirector Declaration
14th Sep 20169:45 amRNSUpdate research from QuotedData
1st Sep 20167:00 amRNSTotal Voting Rights
30th Aug 201611:57 amRNSHolding(s) in Company
26th Aug 20162:37 pmRNSTransaction in Own Shares
22nd Aug 20164:19 pmRNSTransaction in Own Shares
17th Aug 201611:42 amRNSTransaction in Own Shares
12th Aug 20167:00 amRNSEstimated Net Asset Value as at 31 July 2016
5th Aug 201610:46 amRNSTransaction in Own Shares
2nd Aug 20168:29 amRNSDirector Declaration
14th Jul 20167:00 amRNSEstimated Net Asset Value at 30 June 2016
4th Jul 20164:43 pmRNSQuarterly Disclosure
14th Jun 20167:00 amRNSEstimated NAV at 31 May 2016
27th May 20164:24 pmRNSCompany Secretary Change
27th May 20167:02 amRNSEstimated NAV at 30 April 2016
27th May 20167:00 amRNSHalf-year Report
10th May 20163:22 pmRNSInitiation research from QuotedData
14th Apr 20167:00 amRNSEstimated NAV at 31 March 2016
5th Apr 201610:00 amRNSHolding(s) in Company
1st Apr 201610:08 amRNSHolding(s) in Company
1st Apr 20169:24 amRNSQuarterly Disclosure
1st Apr 20169:16 amRNSTotal Voting Rights
31st Mar 20162:45 pmRNSTransaction in Own Shares
24th Mar 20162:05 pmRNSEstimated NAV at 29 February 2016
24th Mar 20162:00 pmRNSQuarterly Trading Statement
26th Feb 201610:48 amRNSDirector/PDMR Shareholding
24th Feb 20164:46 pmRNSEdison update on Standard Life Euro. Pvt. Equity
12th Feb 20167:00 amRNSEstimated NAV at 31 January 2016
20th Jan 20163:12 pmRNSResult of AGM
20th Jan 20163:09 pmRNSEstimated NAV at 31 December 2015
6th Jan 201611:49 amRNSQuarterly Disclosure
17th Dec 20155:00 pmRNSAnnual Financial Report
16th Dec 20153:04 pmRNSDirector/PDMR Shareholding
14th Dec 20157:00 amRNSEstimated NAV at 30 November 2015
7th Dec 20157:01 amRNSEstimated NAV at 31 October 2015
7th Dec 20157:00 amRNSPreliminary Results
14th Oct 20157:00 amRNSEstimated NAV at 30 September 2015
1st Oct 20157:30 amRNSQuarterly Disclosure
1st Oct 20157:30 amRNSTotal Voting Rights
25th Sep 20154:36 pmRNSTransaction in Own Shares
18th Sep 201512:02 pmRNSDebt Facility
16th Sep 20157:05 amRNSEstimated NAV at 31 August 2015
16th Sep 20157:00 amRNSQuarterly Trading Statement
14th Aug 20157:00 amRNSEstimated NAV at 31 July 2015
3rd Aug 201510:00 amRNSTotal Voting Rights
31st Jul 201512:42 pmRNSDirector/PDMR Shareholding
30th Jul 20152:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.